Drugs / [Tc-99m]-RPI-T-087
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03503825 | Aug 2018 → May 2019 | osteoarthritis, knee | Reiley Pharmaceuticals Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [Tc-99m]-RPI-T-087 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03503825 ↗ |
| Modality | Diagnostic / imaging agent | “imaging marker for COX-2” NCT03503825 ↗ |
| Route | Intravenous | “A single intravenous injection of \[Tc-99m\]-RPI-T-087” NCT03503825 ↗ |